Level C· Early human research exploring benefitsProspective StudyPubMed

Cardiac glycosides cause cytotoxicity in human macrophages and ameliorate white adipose tissue homeostasis.

Olona A., Hateley C., Guerrero A., Ko JH., Johnson MR., Anand PK.

Prospective Study on Cardiovascular Disease, published in Br J Pharmacol (2021) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Br J Pharmacol (2021)
Country
England
Reported sample size
—
Source database
PubMed
PMID
33665823
DOI
10.1111/bph.15423
Citations
16

Abstract (original English)

Background and purpose Cardiac glycosides inhibit Na + /K + -ATPase and are used to treat heart failure and arrhythmias. They can induce inflammasome activation and pyroptosis in macrophages, suggesting cytotoxicity, which remains to be elucidated in human tissues. Experimental approach To determine the cell-type specificity of this cytotoxicity, we used human monocyte-derived macrophages and non-adherent peripheral blood cells from healthy donors, plus omental white adipose tissue, stromal vascular fraction-derived pre-adipocytes and adipocytes from obese patients undergoing bariatric surgery. All these cells/tissues were treated with nanomolar concentrations of ouabain (50, 100, 500 nM) to investigate the level of cytotoxicity and the mechanisms leading to cell death. In white adipose tissue, we investigated ouabain-mediated cytotoxicity by measuring insulin sensitivity, adipose tissue function and extracellular matrix deposition ex vivo. Key results Ouabain induced cell death through pyroptosis and apoptosis, and was more effective in monocyte-derived macrophages compared to non-adherent peripheral blood mononuclear cell populations. This cytotoxicity is dependent on K + flux, as ouabain causes intracellular depletion of K + and accumulation of Na + and Ca 2+ . Consistently, the cell death caused by these ion imbalances can be rescued by addition of potassium chloride to hum

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueAdipose Tissue, WhiteCardiac GlycosidesHomeostasisHumansLeukocytes, MononuclearMacrophagesOuabainSodium-Potassium-Exchanging ATPase

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research